procrit vein occlusion Pages on BioPortfolio:

Results from other life science and pharmaceutical sites:

Procrit/Epogen Label
8 Mar 2007 ... occlusion. A rate of hemoglobin rise of greater than 1 g/dL over 2 ... An increased incidence of deep vein thrombosis (DVT) in patients ...
http://www.fda.gov/cder/foi/label/2007/103234s5122lbl.pdf...

Post-ischemic treatment with erythropoietin or carbamylated ...
Recombinant human erythropoietin (rhEPO; Epoetin-α; PROCRIT™) has been shown ..... Zero and 1 day time points represent prior to MCA occlusion and CEPO or
...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=21...

In April, 1993, the Agency approved epoetin alfa (epogen) for ...
In April 1993, Epogen/Procrit was approved for the indication of treatment ...... embolism l month after EPO discontinuation, 1 brachial vein thrombosis).
...
http://www.fda.gov/OHRMS/DOCKETS/ac/04/briefing/4037B2_04_FD...

British Journal of Pharmacology - Post-ischemic treatment with ...
Rats subjected to embolic middle cerebral artery occlusion (MCAo) were treated with .... In this paper, rhEPO refers specifically to Epoetin-Alfa (PROCRIT; ...
http://www.nature.com/bjp/journal/v151/n8/full/0707285a.html...

HealthPartners.com - All Medical Coverage Criteria for MN Plans
... ESA (Erythropoiesis Stimulating Agents, e.g. Procrit, Epogen, and Aranesp ... LVAD - Left Ventricular Assist Device · Lacrimal Punctal Occlusion ...
http://www.healthpartners.com/policies/policyIndex.do?type=1...

Briefing document:
“TVE” included deep vein thrombosis, cardiac arrest, jugular vein thrombosis,. thrombosis, arterial thrombosis, pulmonary embolism, carotid artery occlusion
...
http://www.fda.gov/OHRMS/DOCKETS/AC/07/briefing/2007-4301b2-...

GRANTS: DECEMBER 2006 Dept PI Title ANESTHESIOLOGY & PAIN MEDICINE ...
PROCRIT. INTERNAL MEDICINE. KRAVITZ, RICHARD. PATIENT COACHING TO ...... following central retinal vein. occlusion of branch-vein. occlusion ...
http://www.ucdmc.ucdavis.edu/medresearch/medsp/includes/SOMG...

Erythropoietin reduces myocardial infarction and left ventricular ...
All experiments were performed by using Epoetin Alfa (Procrit, ... 5% Evans blue was injected into the right ventricular chamber via the right jugular vein. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=20...

HealthPartners.com - All Coverage Criteria
... ESA (Erythropoiesis Stimulating Agents, e.g. Procrit, Epogen, and Aranesp ... EVLA (Endovenous laser ablation of saphenous vein) · Ear Lobe Repair ...
http://www.healthpartners.com/policies/policyIndex.do?type=1...

FDA Briefing Document May 4,2004 Oncologic Drugs Advisory ...
occlusion, and death, though the numbers of subject-weeks and events in this ..... FDA noted that Procrit could potentially serve as a growth factor for ...
http://www.fda.gov/ohrms/dockets/AC/04/briefing/4037b2_04.pd...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.